Black Diamond Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Black Diamond Therapeutics's estimated annual revenue is currently $12.9M per year.
- Black Diamond Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Black Diamond Therapeutics has 83 Employees.
- Black Diamond Therapeutics grew their employee count by -11% last year.
Black Diamond Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | VP, Program Management | Reveal Email/Phone |
4 | VP Legal and Intellectual Property | Reveal Email/Phone |
5 | Head Information Technology | Reveal Email/Phone |
6 | SVP Clinical Development | Reveal Email/Phone |
7 | Executive Director, Head Early Development and Discovery Chemistry | Reveal Email/Phone |
8 | Chief Business & Financial Officer | Reveal Email/Phone |
9 | Chief Operating Officer & General Counsel | Reveal Email/Phone |
10 | Executive Director, Head Biometrics and Data Management | Reveal Email/Phone |
Black Diamond Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Black Diamond Therapeutics?
Black Diamond Therapeutics Inc. is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.
keywords:N/A
N/A
Total Funding
83
Number of Employees
$12.9M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Black Diamond Therapeutics News
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, completed a Series C financing of $85m. The round was led by Boxer Capital of the Tavistock Group, with participat ...
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company developing next-generation precision medicines for cancer, completed an $85m Series B financing. The round was co-led by New Enterprise Associates and RA Capital Management, with participation from new investors Ne ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12M | 83 | -72% | N/A |
#2 | $7.5M | 83 | 2% | N/A |
#3 | $12M | 83 | N/A | N/A |
#4 | $75M | 83 | 11% | $39.5M |
#5 | $12.9M | 83 | 14% | N/A |